← All organizations
First clinical trial
Aug 31, 2022Last known activity
Mar 31, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 18 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Recent trials (18)
- NCT07219238CollaboratorPhase 2/Phase 3Mar 31, 2026
- NCT07244705CollaboratorPhase 1/Phase 2Nov 30, 2025
- NCT07109219CollaboratorPhase 1/Phase 2Oct 31, 2025
- NCT07093398CollaboratorPhase 1Jul 11, 2025
- NCT06933472CollaboratorPhase 3Jun 13, 2025
- NCT06916806CollaboratorPhase 1May 1, 2025
- NCT06769633CollaboratorPhase 2Jan 2, 2025
- NCT06713369CollaboratorPhase 1Dec 18, 2024
- NCT06651970CollaboratorPhase 4Nov 30, 2024
- NCT06706817CollaboratorPhase 3Nov 29, 2024
- NCT06692764CollaboratorPhase 2Oct 30, 2024
- NCT06473779CollaboratorPhase 3Sep 30, 2024
- NCT06563102CollaboratorPhase 4Sep 11, 2024
- NCT06495918CollaboratorPhase 3Jul 15, 2024
- NCT06398730CollaboratorPhase 1Jul 2, 2024
Details
- Last known activity
- Mar 31, 2026